These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 26405280)

  • 1. Response to Comments on Nolan et al. Insulin Resistance as a Physiological Defense Against Metabolic Stress: Implications for the Management of Subsets of Type 2 Diabetes. Diabetes 2015;64:673-686.
    Nolan CJ; Ruderman NB; Kahn SE; Pedersen O; Prentki M
    Diabetes; 2015 Oct; 64(10):e38-9. PubMed ID: 26405280
    [No Abstract]   [Full Text] [Related]  

  • 2. Comment on Nolan et al. Insulin Resistance as a Physiological Defense Against Metabolic Stress: Implications for the Management of Subsets of Type 2 Diabetes. Diabetes 2015;64:673-686.
    Zaccardi F; Webb DR; Khunti K; Davies MJ
    Diabetes; 2015 Oct; 64(10):e35-6. PubMed ID: 26405278
    [No Abstract]   [Full Text] [Related]  

  • 3. Comment on Nolan et al. Insulin Resistance as a Physiological Defense Against Metabolic Stress: Implications for the Management of Subsets of Type 2 Diabetes. Diabetes 2015;64:673-686.
    Taegtmeyer H; Beauloye C; Harmancey R; Hue L
    Diabetes; 2015 Oct; 64(10):e37. PubMed ID: 26405279
    [No Abstract]   [Full Text] [Related]  

  • 4. Insulin resistance as a physiological defense against metabolic stress: implications for the management of subsets of type 2 diabetes.
    Nolan CJ; Ruderman NB; Kahn SE; Pedersen O; Prentki M
    Diabetes; 2015 Mar; 64(3):673-86. PubMed ID: 25713189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin resistance - the body's defence against caloric intoxication?
    Methi T; Thorsby PM
    Tidsskr Nor Laegeforen; 2016 Jun; 136(11):1015-7. PubMed ID: 27325036
    [No Abstract]   [Full Text] [Related]  

  • 6. Myocardial insulin resistance, metabolic stress and autophagy in diabetes.
    Mellor KM; Bell JR; Ritchie RH; Delbridge LM
    Clin Exp Pharmacol Physiol; 2013 Jan; 40(1):56-61. PubMed ID: 22804725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mechanisms of insulin resistance].
    Mäkinen S; Skrobuk P; Nguyen YH; Koistinen H
    Duodecim; 2013; 129(20):2115-22. PubMed ID: 24340711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to comment on: Tessari et al. Roles of insulin, age, and asymmetric dimethylarginine on nitric oxide synthesis in vivo. Diabetes 2013;62:2699-2708.
    Tessari P
    Diabetes; 2013 Oct; 62(10):e24. PubMed ID: 24065802
    [No Abstract]   [Full Text] [Related]  

  • 9. Calcium signalling and ER stress in insulin resistance and atherosclerosis.
    Ozcan L; Tabas I
    J Intern Med; 2016 Nov; 280(5):457-464. PubMed ID: 27739133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comment on: Tessari et al. Roles of insulin, age, and asymmetric dimethylarginine on nitric oxide synthesis in vivo. Diabetes 2013;62:2699-2708.
    Kruszelnicka O; Rakowski T; Surdacki A
    Diabetes; 2013 Oct; 62(10):e23. PubMed ID: 24065801
    [No Abstract]   [Full Text] [Related]  

  • 11. JNK at the crossroad of obesity, insulin resistance, and cell stress response.
    Solinas G; Becattini B
    Mol Metab; 2017 Feb; 6(2):174-184. PubMed ID: 28180059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are obesity-related insulin resistance and type 2 diabetes autoimmune diseases?
    Tsai S; Clemente-Casares X; Revelo XS; Winer S; Winer DA
    Diabetes; 2015 Jun; 64(6):1886-97. PubMed ID: 25999531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Insulin resistance and oxidative stress].
    Andreeva-Gateva P
    Vutr Boles; 1999; 31(4):9-19. PubMed ID: 10989670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fructose-mediated stress signaling in the liver: implications for hepatic insulin resistance.
    Wei Y; Wang D; Topczewski F; Pagliassotti MJ
    J Nutr Biochem; 2007 Jan; 18(1):1-9. PubMed ID: 16854579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atherosclerosis in type 2 diabetes mellitus: the role of insulin resistance.
    Watson KE; Peters Harmel AL; Matson G
    J Cardiovasc Pharmacol Ther; 2003 Dec; 8(4):253-60. PubMed ID: 14740074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obstructive sleep apnea: an unexpected cause of insulin resistance and diabetes.
    Morgenstern M; Wang J; Beatty N; Batemarco T; Sica AL; Greenberg H
    Endocrinol Metab Clin North Am; 2014 Mar; 43(1):187-204. PubMed ID: 24582098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemokine Like Receptor-1 (CMKLR-1) Receptor: A Potential Therapeutic Target in Management of Chemerin Induced Type 2 Diabetes Mellitus and Cancer.
    Perumalsamy S; Aqilah Mohd Zin NA; Widodo RT; Wan Ahmad WA; Vethakkan SRDB; Huri HZ
    Curr Pharm Des; 2017; 23(25):3689-3698. PubMed ID: 28625137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Against insulin resistance. Insulin sensitizers].
    Verspohl EJ; Weiland F
    Pharm Unserer Zeit; 2002; 31(3):280-92. PubMed ID: 12071125
    [No Abstract]   [Full Text] [Related]  

  • 19. [Insulin resistance and molecular abnormalities of the insulin receptor in type II diabetes].
    Clauser E; Assan R
    Journ Annu Diabetol Hotel Dieu; 1993; ():23-36. PubMed ID: 8392640
    [No Abstract]   [Full Text] [Related]  

  • 20. Insulin resistance in diabetes mellitus. Defective insulin-regulatable glucose transport plays an important role.
    Livingstone C; Gould GW
    Scott Med J; 1995 Apr; 40(2):37-9. PubMed ID: 7618066
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.